816 related articles for article (PubMed ID: 19035778)
1. Anticardiolipin antibodies in HIV infection are independently associated with antibodies to the membrane proximal external region of gp41 and with cell-associated HIV DNA and immune activation.
Martinez V; Diemert MC; Braibant M; Potard V; Charuel JL; Barin F; Costagliola D; Caumes E; Clauvel JP; Autran B; Musset L;
Clin Infect Dis; 2009 Jan; 48(1):123-32. PubMed ID: 19035778
[TBL] [Abstract][Full Text] [Related]
2. Predictors of virological outcome and safety in primary HIV type 1-infected patients initiating quadruple antiretroviral therapy: QUEST GW PROB3005.
Hoen B; Cooper DA; Lampe FC; Perrin L; Clumeck N; Phillips AN; Goh LE; Lindback S; Sereni D; Gazzard B; Montaner J; Stellbrink HJ; Lazzarin A; Ponscarme D; Staszewski S; Mathiesen L; Smith D; Finlayson R; Weber R; Wegmann L; Janossy G; Kinloch-de Loes S;
Clin Infect Dis; 2007 Aug; 45(3):381-90. PubMed ID: 17599319
[TBL] [Abstract][Full Text] [Related]
3. Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers.
Messele T; Brouwer M; Girma M; Fontanet AL; Miedema F; Hamann D; Rinke de Wit TF
Clin Immunol; 2001 Feb; 98(2):212-9. PubMed ID: 11161977
[TBL] [Abstract][Full Text] [Related]
4. Residual viraemia in HIV-1-infected patients with plasma viral load Ostrowski SR; Katzenstein TL; Pedersen BK; Gerstoft J; Ullum H
Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
[TBL] [Abstract][Full Text] [Related]
5. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
[TBL] [Abstract][Full Text] [Related]
6. Combination of HIV-1-specific CD4 Th1 cell responses and IgG2 antibodies is the best predictor for persistence of long-term nonprogression.
Martinez V; Costagliola D; Bonduelle O; N'go N; Schnuriger A; Théodorou I; Clauvel JP; Sicard D; Agut H; Debré P; Rouzioux C; Autran B;
J Infect Dis; 2005 Jun; 191(12):2053-63. PubMed ID: 15897991
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 viral replication below 50 copies/ml in patients on antiretroviral therapy is not associated with CD8+ T-cell activation.
Steel A; Cox AE; Shamji MH; John L; Nelson M; Henderson DC; Gotch FM; Gazzard BG; Kelleher P
Antivir Ther; 2007; 12(6):971-5. PubMed ID: 17926652
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis of CD4+ and CD19+ cells during human immunodeficiency virus type 1 infection--correlation with clinical progression, viral load, and loss of humoral immunity.
Samuelsson A; Broström C; van Dijk N; Sönnerborg A; Chiodi F
Virology; 1997 Nov; 238(2):180-8. PubMed ID: 9400591
[TBL] [Abstract][Full Text] [Related]
9. Loss of correlation between HIV viral load and CD4+ T-cell counts in HIV/HTLV-1 co-infection in treatment naive Mozambican patients.
Bhatt NB; Gudo ES; Semá C; Bila D; Di Mattei P; Augusto O; Garsia R; Jani IV
Int J STD AIDS; 2009 Dec; 20(12):863-8. PubMed ID: 19948902
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms involved in the low-level regeneration of CD4+ cells in HIV-1-infected patients receiving highly active antiretroviral therapy who have prolonged undetectable plasma viral loads.
Benveniste O; Flahault A; Rollot F; Elbim C; Estaquier J; Pédron B; Duval X; Dereuddre-Bosquet N; Clayette P; Sterkers G; Simon A; Ameisen JC; Leport C
J Infect Dis; 2005 May; 191(10):1670-9. PubMed ID: 15838794
[TBL] [Abstract][Full Text] [Related]
11. Proportions of circulating T cells with a regulatory cell phenotype increase with HIV-associated immune activation and remain high on antiretroviral therapy.
Lim A; Tan D; Price P; Kamarulzaman A; Tan HY; James I; French MA
AIDS; 2007 Jul; 21(12):1525-34. PubMed ID: 17630546
[TBL] [Abstract][Full Text] [Related]
12. CD4 cell count and HIV DNA level are independent predictors of disease progression after primary HIV type 1 infection in untreated patients.
Goujard C; Bonarek M; Meyer L; Bonnet F; Chaix ML; Deveau C; Sinet M; Galimand J; Delfraissy JF; Venet A; Rouzioux C; Morlat P;
Clin Infect Dis; 2006 Mar; 42(5):709-15. PubMed ID: 16447119
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 IgA specific serum antibodies and disease progression during HIV-1 infection.
Margalith M; Levy E; Rinaldo CR; Detels R; Phair J; Kaslow R; Saah AJ; Sarov B
J Hum Virol; 2001; 4(5):269-77. PubMed ID: 11907384
[TBL] [Abstract][Full Text] [Related]
14. T cell activation in HIV-seropositive Ugandans: differential associations with viral load, CD4+ T cell depletion, and coinfection.
Eggena MP; Barugahare B; Okello M; Mutyala S; Jones N; Ma Y; Kityo C; Mugyenyi P; Cao H
J Infect Dis; 2005 Mar; 191(5):694-701. PubMed ID: 15688282
[TBL] [Abstract][Full Text] [Related]
15. Relationship of antibodies against CD4+ T cells in HIV-infected patients to markers of activation and progression: autoantibodies are closely associated with CD4 cell depletion.
Müller C; Kukel S; Bauer R
Immunology; 1993 Jun; 79(2):248-54. PubMed ID: 8102120
[TBL] [Abstract][Full Text] [Related]
16. [Investigation of anti-R7V antibodies in HIV-infected patients under highly active antiretroviral therapy].
Ergünay K; Altinbaş A; Calik Başaran N; Unal S; Us D; Karabulut E; Ustaçelebi S
Mikrobiyol Bul; 2008 Jul; 42(3):413-9. PubMed ID: 18822884
[TBL] [Abstract][Full Text] [Related]
17. Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy.
Cohen Stuart JW; Velema M; Schuurman R; Boucher CA; Hoepelman AI
J Med Virol; 2009 Mar; 81(3):441-5. PubMed ID: 19152397
[TBL] [Abstract][Full Text] [Related]
18. Coinfection with herpes simplex virus type 2 is associated with reduced HIV-specific T cell responses and systemic immune activation.
Sheth PM; Sunderji S; Shin LY; Rebbapragada A; Huibner S; Kimani J; Macdonald KS; Ngugi E; Bwayo JJ; Moses S; Kovacs C; Loutfy M; Kaul R
J Infect Dis; 2008 May; 197(10):1394-401. PubMed ID: 18444797
[TBL] [Abstract][Full Text] [Related]
19. CD4+ T cell-dependent reduction in hepatitis C virus-specific humoral immune responses after HIV infection.
Netski DM; Mosbruger T; Astemborski J; Mehta SH; Thomas DL; Cox AL
J Infect Dis; 2007 Mar; 195(6):857-63. PubMed ID: 17299716
[TBL] [Abstract][Full Text] [Related]
20. Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy: association of immune activation, T cell maturation markers, and cellular HIV-1 DNA.
Goicoechea M; Smith DM; Liu L; May S; Tenorio AR; Ignacio CC; Landay A; Haubrich R
J Infect Dis; 2006 Jul; 194(1):29-37. PubMed ID: 16741879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
